<?xml version="1.0" encoding="UTF-8"?>
<p>In general, 25% of the genome difference of enterovirus is used as the criteria for serotyping, while 15% of the genome difference is used as the criteria for genotyping; this is widely accepted for serotyping and genotyping of enterovirus, such as EV-A71, CV-A16, and CV-A6 (
 <xref rid="B5" ref-type="bibr">Brown et al., 1999</xref>; 
 <xref rid="B32" ref-type="bibr">Oberste et al., 1999a</xref>, 
 <xref rid="B33" ref-type="bibr">b</xref>; 
 <xref rid="B30" ref-type="bibr">Mizuta et al., 2005</xref>; 
 <xref rid="B61" ref-type="bibr">Zhang et al., 2010a</xref>, 
 <xref rid="B60" ref-type="bibr">2013</xref>; 
 <xref rid="B41" ref-type="bibr">Song et al., 2017</xref>). We refer to the published genotyping criteria of EV-A71, CV-A16, and CV-A6 and combined with the latest research progress of E-30 (
 <xref rid="B24" ref-type="bibr">Lema et al., 2019</xref>; 
 <xref rid="B26" ref-type="bibr">Maruo et al., 2019</xref>; 
 <xref rid="B27" ref-type="bibr">Mauri et al., 2019</xref>; 
 <xref rid="B42" ref-type="bibr">Sousa et al., 2019</xref>). In addition to being able to better represent the E-30 sequences in the world, we also avoid the redundancy sequences of E-30 for genotyping, which leads to the confusion and divergence of enterovirus genotyping.
</p>
